Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh(CRUK Lung Cancer Centre of Excellence), Nicolai J. Birkbak(The Francis Crick Institute), Gareth A. Wilson(The Francis Crick Institute), Mariam Jamal‐Hanjani(CRUK Lung Cancer Centre of Excellence), T Constantin(Natera (United States)), Raheleh Salari(Natera (United States)), John Le Quesne(University of Leicester), David A. Moore(University of Leicester), Selvaraju Veeriah(CRUK Lung Cancer Centre of Excellence), Rachel Rosenthal(CRUK Lung Cancer Centre of Excellence), Teresa Marafioti(University College Hospital), Eser Kırkızlar(Natera (United States)), Thomas B. K. Watkins(The Francis Crick Institute), Nicholas McGranahan(The Francis Crick Institute), Sophia Ward(The Francis Crick Institute), Luke Martinson(University of Leicester), Joan Riley(University of Leicester), Francesco Fraioli(University College Hospital), Maise Al Bakir(The Francis Crick Institute), Eva Grönroos(The Francis Crick Institute), Francisco Zambrana(CRUK Lung Cancer Centre of Excellence), Raymondo Endozo(University College Hospital), Wenya Linda Bi(Brigham and Women's Hospital), Fiona M. Fennessy(Brigham and Women's Hospital), Nicole Sponer(Natera (United States)), Diana Johnson(CRUK Lung Cancer Centre of Excellence), Joanne Laycock(CRUK Lung Cancer Centre of Excellence), Seema Shafi(CRUK Lung Cancer Centre of Excellence), Justyna Czyzewska-Khan(CRUK Lung Cancer Centre of Excellence), Andrew Rowan(The Francis Crick Institute), Tim Chambers(The Francis Crick Institute), Nik Matthews(Institute of Cancer Research), Samra Turajlic(The Francis Crick Institute), Crispin T. Hiley(The Francis Crick Institute), Siow Ming Lee(University College Hospital), Martin Förster(University College Hospital), Tanya Ahmad(University College Hospital), Mary Falzon(University College Hospital), Elaine Borg(University College Hospital), David Lawrence(University College Hospital), Martin Hayward(University College Hospital), Shyam Kolvekar(University College Hospital), Nikolaos Panagiotopoulos(University College Hospital), Sam M. Janes(University College Hospital), Ricky M. Thakrar(University College Hospital), Asia Ahmed(University College Hospital), Fiona Blackhall(Cancer Research UK Manchester Institute), Yvonne Summers(The Christie Hospital), Dina Hafez(Natera (United States)), Ashwini Naik(Natera (United States)), Apratim Ganguly(Natera (United States)), Stephanie Kareht(Natera (United States)), Rajesh Shah(University Dental Hospital of Manchester), Leena Dennis Joseph(Withington Community Hospital), Anne Marie Quinn(Withington Community Hospital), Philip Crosbie(Withington Community Hospital), Babu Naidu(University Hospitals Birmingham NHS Foundation Trust), Gary Middleton(University of Birmingham), Gerald Langman(Heartlands Hospital), Simon Trotter(Heartlands Hospital), M. Nicolson(Aberdeen Royal Infirmary), Hardy Remmen(Aberdeen Royal Infirmary), Keith M. Kerr(Aberdeen Royal Infirmary), Mahendran Chetty(Aberdeen Royal Infirmary), Lesley Gomersall(Aberdeen Royal Infirmary), Dean A. Fennell(University of Leicester), Apostolos Nakas(Glenfield Hospital), Sridhar Rathinam(Glenfield Hospital), Girija Anand(North Middlesex Hospital), Sajid Khan(The Royal Free Hospital), Peter Russell(Princess Alexandra Hospital NHS Trust), Veni Ezhil(Royal Surrey County Hospital), Babikir Ismail(Ashford and St Peter's Hospitals NHS Foundation Trust), Melanie Irvin-Sellers(St Peter's Hospital), Vineet Prakash(Ashford and St Peter's Hospitals NHS Foundation Trust), J.F. Lester(Velindre Cancer Centre), Malgorzata Kornaszewska(University Hospital of Wales), Richard Attanoos(University Hospital of Wales), Haydn Adams(University Hospital Llandough), Helen Davies(University Hospital Llandough), Dahmane Oukrif(CRUK Lung Cancer Centre of Excellence), Ayse U. Akarca(CRUK Lung Cancer Centre of Excellence), John A. Hartley(CRUK Lung Cancer Centre of Excellence), Helen L. Lowe(CRUK Lung Cancer Centre of Excellence), Sara Lock(Whittington Hospital), Natasha Iles(Cancer Research UK), Harriet Bell(Cancer Research UK), Yenting Ngai(Cancer Research UK), Greg Elgar(The Francis Crick Institute), Zoltán Szállási(Semmelweis University), Roland F. Schwarz(Max Delbrück Center), Javier Herrero(CRUK Lung Cancer Centre of Excellence), Aengus Stewart(The Francis Crick Institute), Sergio A. Quezada(CRUK Lung Cancer Centre of Excellence), Karl S. Peggs(CRUK Lung Cancer Centre of Excellence), Peter Van Loo(The Francis Crick Institute), Caroline Dive(University of Manchester), C Jimmy Lin(Natera (United States)), Matthew Rabinowitz(Natera (United States)), Hugo J.W.L. Aerts(Brigham and Women's Hospital), Allan Hackshaw(Cancer Research UK), Jacqui Shaw(University of Leicester), Bernhard Zimmermann(Natera (United States)), Charles Swanton(The Francis Crick Institute)
Cited by 1,880Open Access
Abstract
Related Papers
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R Aberle, Amanda M Adams, Christine D Berg et al.|New England Journal of Medicine|2011|10.9k
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al.|Journal of Clinical Oncology|2008|2.7k